MED Share Price Performance
CHF 76.90
76.90 (0.00%)
19.9% undervalued intrinsic discount
CHF 95.97
Fair Value
Price CHF 76.90
AnalystConsensusTarget CHF 95.97
Fair ValueCHF 95.97
Share Pricen/a
Medartis Holding AG Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
MED Community Narratives
AN
Fair Value
·Fair Value CHF 95.97 19.9% undervalued intrinsic discount
Orthopedic Demand And Digital Solutions Will Expand Global Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Orthopedic Demand And Digital Solutions Will Expand Global Reach
Key Takeaways Expansion into high-growth global markets and advanced personalized implant solutions positions Medartis for greater revenue and margin gains in premium healthcare segments. Investments in operational efficiency and strong competitive barriers strengthen the company's stability and profitability amid industry and macroeconomic challenges.Read more
AN
CHF 95.97
19.9% undervalued intrinsic discount
Fair Value
Revenue
18.2% p.a.
Profit Margin
8.45%
Future PE
35.57x
Price in 2029
CHF 107.16
Trending Discussion
Recently Updated Narratives
AN
MED: Slightly Higher Margins And Stable Outlook Will Support Future Upside
Fair Value: CHF 95.97 19.9% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medartis Holding AG Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
- 0.67
- 75.89%
- 3.10%
- 47.3%
About MED
- Founded
- 1997
- Employees
- 1259
- CEO
- WebsiteView website
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
